Walgreens Boots Alliance Reports Fiscal 2015 Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- Wall St slides as oil tops $100, yields hit 2023 high; Apple down before Ternus' first launch event as CEO
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- Oil nears $100 as fresh Middle East strikes raise supply risks
- How big a risk are rates to the AI boom?
- 3 reasons why S&P 500 may drop up to 10% in the near term: RBC
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Rite Aid (RAD) Bounces Off Lows
April 10, 2015 11:53 AM EDTRite Aid (NYSE: RAD) shares bounced off lows near $8.10 late on Friday morning. The stock was pressured the last two sessions following its Q4 results and due to M&A-related comments made during Walgreen Boots Alliance's (NASDAQ:... More
Deutsche Bank Comments Following Walgreens Boosts (WBA) Q2 Results (ESRX)
April 10, 2015 7:21 AM EDTDeutsche Bank maintained a Buy rating on Walgreens Boosts Alliance (NASDAQ: WBA) with a price target of $89. Comments follow Q2 results. Analyst George Hill pointed out guidance was in line with the Street. He also touched on rumors it could acquire Express Scripts (NASDAQ: ESRX).
"Walgreens reported F2Q15 results that exceeded expected EPS expectations... More
Evercore ISI Discusses Walgreens Boosts Alliance (WBA) M&A and JVs
April 9, 2015 4:02 PM EDTSpeculation has been hot in the PBM/Pharmacy space today following Walgreens Boosts Alliance (NASDAQ: WBA) earnings conference call. Evercore ISI analyst Ross Muken offer his thoughts on the situation in a note to clients this afternoon.
Read-through to ESRX (Nasdaq: ESRX): The market clearly interpreted today's commentary on the CC as an open invitation for talks with key peer ESRX. While we believe some sort of relationship has a ton of merit... More
Walgreens (WBA) Likely to Pursue Acquisition or JV Near-Term, Leerink Says (RAD) (ABC) (ESRX)
April 9, 2015 11:54 AM EDTLeerink Partners analyst David Larsen weighed in on Walgreens Boosts Alliance (NASDAQ: WBA) after today's earnings. The analyst notes management is aggressively pursuing new U.S. retail synergies and M&A is on the horizon. The firm maintained an Outperform rating and price target of $85.00
Larsen commented, "During the call management indicated that... More
Walgreen Boots Alliance (WBA) Tops Q2 EPS by 23c
April 9, 2015 7:02 AM EDTWalgreen Boots Alliance (Nasdaq: WBA) reported Q2 EPS of $1.18, $0.23 better than the analyst estimate of $0.95. Revenue for the quarter came in at $26.6 billion versus the consensus estimate of $27.27 billion.
The Retail Pharmacy USA division, whose principal retail pharmacy brands are Walgreens and Duane... More
